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HIV-infected adults are at an increased risk to lower respiratory tract infections (LRTIs).
CD8+CD161++TCRvα7.2+ T cells are an innate-like T cell subset that are thought to play
an important role in early defense against pathogens in the respiratory tract. HIV infection
leads to irreversible depletion of these cells in peripheral blood, however, its impact on this
subset in the human airway is still unclear. Here, we show presence of CD103 expressing
CD8+CD161++TCRvα7.2+ T cells in the airway that exhibited a distinct cytokine
functional profile compared to their CD103− airway counterparts and those from
peripheral blood. These CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells
were selectively depleted in untreated HIV-infected adults compared to healthy controls.
Their frequency was positively correlated with frequency of airway CD4+ T cells.
Furthermore, the frequency of airway CD8+CD161++TCRvα7.2+ T cells was also
inversely correlated with HIV plasma viral load, while suppressive antiretroviral therapy
(ART) resulted in restoration of airway CD8+CD161++TCRvα7.2+ T cells. Our findings
show that CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells are functionally
distinct and are preferentially depleted during untreated asymptomatic HIV infection.
Depletion of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells, at a major
portal of pathogen entry, could partly contribute to the increased propensity for
opportunistic LRTIs observed in untreated HIV-infected adults.
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INTRODUCTION
HIV-infected individuals are at an increased risk to lower respiratory tract infections (LRTIs) (1, 2),
which account for 75–98% of lung complications in untreatedHIV-infected adults worldwide (3, 4).
This susceptibility to LRTIs is largely attributed to HIV-induced disruption of lung immunity,
including global alteration in airway immune cell homeostasis (5), reduced frequency of respiratory
antigen-specific airway CD4+ T cells (6, 7), as well as, impaired alveolar macrophage function
(6, 8). While these immune cell perturbations partly underlie propensity for LRTIs in HIV-infected
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individuals, the impact of HIV infection on other important
cells involved in early defense (9, 10), such as airway
CD161++TCRvalpha (α)7.2+ T cells, is not well defined.
CD161++TCRvα7.2+ are classical markers for Mucosal-
Associated Invariant T (MAIT) cells, which are innate-like
T cells present in the liver, blood and mucosal tissues
including gut, female genital tract (FGT) and the lung (11–
14). CD161++TCRvα7.2+ T cells have characteristics of innate
cells and a degree of sophistication possessed by adaptive
lymphocytes. They express a semi-invariant T cell receptor, which
recognizes microbial vitamin B2 (riboflavin) metabolites (5-
(2-oxoethylideneamino)-6-D-ribitylaminouracil or 5-OP-RU),
presented via major histocompatibility complex (MHC) class
I-related (MR) 1 molecule (14–17). CD161++TCRvα7.2+ T
cells are present in three main subsets, CD4−CD8− (DN),
CD4+, and CD8+ phenotypes (18, 19). The majority of the
CD161++TCRvα7.2+ T cells in peripheral blood are actually
of the CD8+ phenotype (18). Mature CD161++TCRvα7.2+
T cells display an effector memory phenotype (20), are pre-
armed with pro-inflammatory and cytolytic effector molecules
(12, 21). This allows them to either lyse infected cells or activate
phagocytes very early after infection (22, 23). Furthermore,
CD161++TCRvα7.2+ T cells contribute to regulation of
mucosal barrier integrity by secreting IL-22, which promotes
epithelial cell proliferation and epithelial tight junction protein
expression (24, 25). These qualities highlight the importance
of CD161++TCRvα7.2+ T cells in antimicrobial defense and
preservation of mucosal barrier integrity.
CD161++TCRvα7.2+ T cells in the human lower respiratory
tract (LRT) are thought to play an important role in defense
against respiratory pathogens. Streptococcus pneumoniae and
Mycobacterium tuberculosis both induce CD161++TCRvα+ T
cell responses through MR1-dependent pathways (16, 26).
In patients with active pulmonary TB, CD161++TCRvα7.2+
T cells are enriched in the lung (16) and decreased in
blood (16, 27, 28). It has been shown that decrease in
MAIT cells frequencies is linked to expression of PD-
1 on MAIT cells during HIV and chronic hepatitis C
virus (HCV) infection (29, 30). It was suggested that this
expression of PD-1 potentially induces inhibition of MAIT cell
proliferation and function due to immune exhaustion (31). In
an experimental murine M. tuberculosis infection, mice over-
expressing CD161++TCRvα7.2+ T cells have lower bacilli load
compared to MR1 knockout (KO) mice (32). This effect of
CD161++TCRvα7.2+ T cells in the lung happens early in
infection. In a M. bovis pulmonary infection model, higher
bacterial burdens are only observed at day 10 in MR1 KO
mice compared to wild type mice (33), but not at day 30,
suggesting that the impact of CD161++TCRvα7.2+ T cells in
controlling bacterial load is much more significant in early than
later stages of infection. An intranasal infection of Francisella
tularensis live-vaccine strain (LVS) in wild-type and MR1 KO
mice, has also established that CD161++TCRvα7.2+ T cells
have a direct early antibacterial effect in the lung and a
sustained impact on development of effective adaptive mucosal
immune response (10). Taken together these findings suggest
that CD161++TCRvα7.2+ T cells in the mucosal surface of the
LRT are poised to provide early control of infection and mediate
development of subsequent optimal adaptive immune responses.
HIV infection leads to depletion of peripheral blood
CD161++TCRvα+ T cells (34, 35), which is not reversed by anti-
retroviral therapy (ART) (36). However, there are conflicting
data on the impact of HIV on the functional capacity of
CD161++TCRvα7.2+ T cells (37, 38). CD161++TCRvα7.2+ T
cells obtained from untreated HIV-infected individuals were
shown to retain their ability to produce IFN-γ and TNF upon
stimulation with purified MR1 ligand (37). In contrast, following
bacterial (E. coli) stimulation, CD161++TCRvα+ T cells from
untreated HIV-infected individuals were shown to produce lower
levels of IFN-γ, TNF, and IL-17 compared to healthy controls
(38). Nevertheless, disruption of this important T cell subset
likely contributes to increased susceptibility to infection in HIV-
infected adults.
Despite important recent advances in CD161++TCRvα7.2+
T cell biology, the phenotype and functional characteristics
of human airway CD161++TCRvα7.2+ T cells in health and
asymptomatic HIV infection are not well-defined. Accumulating
evidence suggests that CD161++TCRvα7.2+ T cells in mucosal
sites may differ from those in circulation (12, 13, 39). To address
this knowledge gap, we examined the frequency, phenotype and
functional capacity of human airway CD161++TCRvα7.2+ T
cells in healthy controls and asymptomatic HIV-infected adults
before and 1 year after initiation of ART.
MATERIALS AND METHODS
Study Participants
We recruited 80 individuals, classified as HIV-
uninfected (n = 39), untreated asymptomatic HIV-infected
(n = 41), and HIV-infected on ART (n = 6) at Queen Elizabeth
Central Hospital, in Blantyre, Malawi. Participants were recruited
from the hospital’s Voluntary Counseling and Testing (VCT)
clinic and they were all of black African origin. They were
asymptomatic adults (≥18 years) with no clinical evidence of
active disease, willing to undergo bronchoscopy and BAL for
research purposes. Exclusion criteria for the study were current
smoker, use of immunosuppressive drugs including ART at
recruitment, and known or suspected pregnancy as screened
by the study clinical team. Untreated HIV-infected individuals
were commenced on ART in line with the “test and treat”
strategy soon after undergoing bronchoscopy (within 36 h post
HIV diagnosis). Participant demographics including age, sex,
CD4 count, and plasma viral load are summarized in Table 1.
All enrolled participants gave written informed consent as per
protocol approved by College of Medicine Research Ethics
Committee (COMREC; protocol P.03/16/1907) and Liverpool
School of Tropical Medicine Research Ethics Committee (LSTM
REC; protocol 15.054). Due to limitation in cell numbers, not all
experiments were done on all samples. Specifically, the frequency
of CD161++TCRvα7.2+ T cell data was generated on all 80
samples, the CD103 containing panel was used to generate data
on a subset of 40 samples and the cytokine functional profile data
was generated on a subset of 22 samples. Furthermore, for this
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TABLE 1 | Demographics of study participants.
HIV-uninfected
controls (n = 39)
HIV-infected
adults (n = 41)
p-value
Age (years) 32 32 0.4063*
Median (range) (18–52) (21–58)
Sex (M:F) 30:9 21:20 0.0398**
CD4 count (cells/µl), 671 319 <0.0001*
Median (IQR) (523–815) (213–471)
Plasma viral load (log 10 N/A 4.08 N/A
Copies/mL), Median (range) (2.2–5.8)
*Unpaired T-test.
**Fishers exact test.
IQR, Interquartile range; ART, antiretroviral therapy; N/A, not applicable.
study, we only had access to paired BAL and peripheral blood
samples from HIV-uninfected individuals.
Sample Collection and Experimental
Procedures
Bronchoscopy and bronchoalveolar lavage (BAL) were
performed on all participants as previously described (5). Paired
peripheral blood was also obtained from study participants for
CD4 count and peripheral blood mononuclear cell (PBMC)
isolation using density gradient centrifugation. Cell counts in
BAL cells and PBMCs isolated from each sample were performed
using a hemocytometer.
Flow Cytometry
Immunophenotyping was performed as previously
described (40). The antibodies used are described in
Supplementary Table 1. BAL cells and PBMCs stimulations
were performed using PMA/Ionomycin (Sigma Aldrich, UK) as
a stimulant. Briefly, cells were incubated at a concentration of 1
× 106 cells/200 µl in complete medium (200 µl per condition) in
the presence of PMA/Ionomycin, BDGolgiPlug (BD Biosciences,
UK) and BD GolgiStop (BD Biosciences, UK) for a total of 6 h
at 37◦C in a 5% CO2 incubator. After stimulation, cells were
harvested and washed in PBS. Cells were labeled with the amine
reactive dye LIVE/DEAD Fixable Aqua (Molecular Probes,
Invitrogen, UK) prior to incubation with antibodies against
surface proteins. Cytokines were stained after subsequent
fixation/permeabilization with BD Cytofix/Cytoperm (BD
Biosciences, UK).
Cytometric Analyses
For all flow cytometric assays, at least 5,000 events in the
CD8+ T cell gate were acquired using a LSRFortessa equipped
with FACSDIVA software (BD Biosciences). Data were analyzed
with FlowJo software (version 10.4.0, Tree Star). For cytokine
functional profiles, PESTLE 1.7 and SPICE 5.3 (both NIAID,
USA) were used for analysis. The programs PESTLE and SPICE
were kindly provided by Mario Roederer, Vaccine Research
Center, NIAID, NIH.
Statistical Analysis
Statistical analyses and graphical presentation were performed
using GraphPad Prism 5 (GraphPad Software, USA). Non-
parametric tests were used to determine significance between
groups using the Mann-Whitney two-tailed test (for two groups)
or the Wilcoxon matched-pairs two-tailed test (for paired
samples) (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001). Pearson test was
used to measured association between parameters.
RESULTS
CD8+CD161++TCRvα7.2+ T Cells Are
Present at Similar Frequencies in the
Airway Lumen and Systemic Circulation
To determine frequency of CD8+CD161++TCRvα7.2+
T cells from the airway lumen and systemic circulation,
we obtained BAL fluid and peripheral blood from healthy
HIV-uninfected adults, respectively (Table 1). Using flow
cytometric analysis (Figure 1A; Supplementary Figure 1),
we found similar frequencies of CD8+CD161++TCRvα7.2+
T cells in airway and peripheral blood samples (Figure 1B).
As expected, the majority of CD8+CD161++TCRvα7.2+
T cells from both airways and blood exhibited a memory
phenotype (CD45RO+) (94% [75–100] vs. 84% [76–90],
p = 0.4867; Figure 1C). CD8+CD161++TCRvα7.2+ T
cells were predominantly MR1 5-OP-RU positive (70%)
and were the most abundant MR1 5-OP-RU positive
population (Supplementary Figures 2, 3). However, due
to low event numbers in the airway CD8−CD4−(DN)
CD161++TCRvα7.2+ T cell population, we have only focused
on the CD8+CD161++TCRvα7.2+ T cell population in this
manuscript. These results confirm the presence of mature
CD8+CD161++TCRvα7.2+ T cells in the airway of Malawian
HIV-uninfected adults.
CD103 Expressing
CD8+CD161++TCRvα7.2+ T Cells Are the
Predominantly Located in the Airway
Lumen Compared to Systemic Circulation
We then further characterized the phenotype of the
CD8+CD161++TCRvα7.2+ T cells by measuring CD103, a
mucosal retention receptor commonly used to differentiate
tissue-resident from infiltrating cells. CD103 is required
for retention of cells in tissues as it binds to epithelial
cell-expressed E-cadherin (41, 42). The proportion of
CD8+CD161++TCRvα7.2+ T cells expressing CD103
was higher in airway compared to blood (77%[46–49] vs.
2% [0.32–2.6], p < 0.0001; Figures 2A,B). Furthermore,
airway CD8+CD161++TCRvα7.2+ T cells expressed
higher levels of CD103 compared to airway classical
CD8+ T cells (Figure 2C). These results show that airway
CD8+CD161++TCRvα7.2+ T cells are predominantly
resident cells, but also contains a subset of potentially
circulating/non-resident cells.
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FIGURE 1 | Identification of CD8+CD161++TCRvα7.2+ T cells in airway lumen and peripheral circulation. BAL cells and PBMCs from HIV-uninfected adults were
stained with fluorochrome-conjugated antibodies against surface markers of interest. (A) Representative flow cytometry plots showing CD8+CD161++TCRvα7.2+ T
cells in matched BAL and PBMC samples from a healthy HIV-uninfected adult. (B) Frequency of CD8+CD161++TCRvα7.2+ T cells in BAL compared to blood. (C)
Memory phenotype of CD8+CD161++TCRvα7.2+ T cells in BAL compared to blood. Data were analyzed using Wilcoxon matched-pairs signed rank test (n = 20).
BAL, bronchoalveolar lavage; PBMC, peripheral blood mononuclear cells.
CD103 Expressing Airway
CD8+CD161++TCRvα7.2+ T Cells Possess
a Distinct Cytokine Functional Profile
Next, we tested whether CD103 expressing airway
CD8+CD161++TCRvα7.2+ T cells were functionally distinct
from CD8+CD161++TCRvα7.2+ T cells in peripheral blood
(Supplementary Figure 4). The cytokine functional profile was
different between airway and blood CD8+CD161++TCRvα+
T cells (Figure 3A). Specifically, a greater proportion of airway
CD8+CD161++TCRvα7.2+ T cells were bi-functional compared
to those from blood (BAL CD103+ 60% vs. Blood CD103− 30%,
p < 0.0001; BAL CD103− 65% vs. Blood CD103− 30%, p =
0.0018). Furthermore, the frequency of IFN-γ & TNF & IL-17A
triple-producers, TNF & IL-17A duo-producers, IL-17A single-
producers, and IFN-γ single-producers were higher in airway
CD103+CD8+CD161++TCRvα7.2+ T cells than peripheral
blood CD103−CD8+CD161++TCRvα7.2+ T cells (p < 0.01, p
< 0.05, p < 0.01, and p < 0.05, respectively; Figure 3A). On the
other hand, the frequency of TNF single-producers were higher
in peripheral blood CD103−CD8+CD161++TCRvα7.2+ T cells
than in CD103 expressing airway CD8+CD161++TCRvα7.2+ T
cells (p< 0.01; Figure 3A).
We then investigated whether there was a
functional difference between CD103 expressing
CD8+CD161++TCRvα7.2+ T cells compared to non CD103
expressing cells from the airway lumen. The frequency of TNF
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FIGURE 2 | Characterization of CD8+CD161++TCRvα7.2+ T cells in airway lumen and peripheral circulation. BAL cells and PBMCs from HIV-uninfected adults were
stained with fluorochrome-conjugated antibodies against surface markers of interest. (A) Representative flow cytometry plots showing CD103 expression in CD8+ T
cells in matched BAL and PBMC samples from two healthy HIV-uninfected adults. (B) Proportion of CD103 expressing CD8+CD161++TCRvα7.2+ T cells in BAL
and PBMCs. (C) CD103 expression intensity in CD8+CD161++TCRvα7.2+ T cells compared to classical CD8+ T cells from the airway lumen. Data were analyzed
using Wilcoxon matched-pairs signed rank test (n = 19). BAL, bronchoalveolar lavage; PBMC, peripheral blood mononuclear cells.
and IL-17A duo-producers was higher in CD103 expressing
than in non CD103 expressing cells (p < 0.01; Figure 3A).
Furthermore, the frequency of CD8+CD161++TCRvα7.2+ T
cells and classical CD8+ T cells from the airways producing
IL-17A was higher in CD103 expressing compared to non
CD103 expressing cells (Figure 3B), but this was not
the case with IFN-γ or TNF (Supplementary Figure 5).
Collectively, the results indicate that CD103 expressing airway
CD8+CD161++TCRvα7.2+ T cells are functionally distinct,
and that CD103 expression is associated with a propensity for
IL-17A-production in airway CD8+ T cells.
Selective Depletion of Airway CD103
Expressing CD8+CD161++TCRvα7.2+ T
Cells in Untreated HIV-Infected Adults
HIV is associated with a depletion of peripheral blood
CD161++TCRvα7.2+ T cells (34, 35), we investigated whether
asymptomatic HIV infection alters the frequency of airway
CD8+CD161++TCRvα7.2+ T cells. The frequency of airway
CD8+CD161++TCRvα7.2+ T cells was significantly lower in
untreated HIV-infected individuals compared to healthy controls
(Figures 4A,B). In a subset of individuals, with paired CD8+ and
DN CD161++TCRvα7.2+ T cells, we found no difference in this
population between HIV-infected adults compared to healthy
controls (Supplementary Figure 3). Specifically, the frequency
of CD103 expressing airway CD8+CD161++TCRvα7.2+
T cells was lower in untreated HIV-infected adults than
in HIV-uninfected controls, but the frequency of non
CD103 expressing airway CD8+CD161++TCRvα7.2+ T
cells was similar between the two groups (Figure 4C). In
contrast, the frequency of total CD8+ T cell was higher
in untreated HIV-infected adults than in HIV-uninfected
controls (Figure 4D).
Furthermore, there was reduction in the distribution
of CD103 expressing airway CD8+CD161++TCRvα7.2+ T
cells in untreated HIV-infected adults compared to HIV-
uninfected adults (52 vs. 78%, p < 0.001; Figure 4E). We
also found that the frequency of CD103 expressing airway
CD8+CD161++TCRvα7.2+ T cells was positively correlated
with the frequency of airway CD4+ T cells (p = 0.0273,
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FIGURE 3 | Functional profile of CD8+CD161++TCRvα7.2+ T cells in airway lumen and peripheral circulation. BAL cells and PBMCs from HIV-uninfected adults
were stimulated with PMA/Ionomycin for 6 h and responses were measured by intracellular cytokine staining for TNF, IFN-γ, and IL-17A. The response was obtained
by gating on singlets, lymphocytes, viable (LIVE/DEAD Aqua), CD3+ cells, CD8+ cells/ CD8+CD161++ TCRvα7.2+ T cells and combination of three cytokines. (A)
Each pie chart (top) represents the mean distribution across subjects of mono-functional, bi-functional and poly-functional cytokine producing cells (color coded as
shown) within the total response in a particular CD161++TCRvα7.2+ T cell population. Bar charts (bottom) represent the mean and standard error of the mean (SEM)
of the contribution of the indicated subset (x-axis) toward the total response against the indicated CD161++TCRvα7.2+ T cell subsets (color coded as shown).
Permutation test was performed among the pie charts and Wilcoxon test was done among the bar charts using SPICE software (*p < 0.05, **p < 0.01). (B)
Frequency of IL17A-producing cells in the CD103+ or CD103− CD8+ T cell/CD8+CD161++TCRvα7.2+ T cell populations subtracting background responses
obtained from the non-stimulated controls. The horizontal bars represent median, interquartile range and highest/lowest value. Data were analyzed using Mann
Whitney test (n = 11). BAL, bronchoalveolar lavage; IFN, interferon-gamma; TNF, tumor necrosis factor; IL17, interleukin-17A.
r = 0.3490; Figure 4F). Collectively, these findings show
that depletion of airway CD8+CD161++TCRvα7.2+ T cells in
untreated HIV-infected adults targets the CD103 expressing cells.
HIV Viral Burden Is Associated With the
Frequency of Airway
CD8+CD161++TCRvα7.2+ T Cells
HIV has direct pro-apoptotic impact on diverse cell types
(43). We therefore determined whether the depletion of airway
CD8+CD161++TCRvα7.2+ T cells is associated with HIV viral
burden. We measured the association between HIV plasma
viral load or peripheral blood CD4 count with frequency
of airway CD8+CD161++TCRvα7.2+ T cells in 25 untreated
HIV-infected adults with complete data. We found that HIV
plasma viral load was inversely correlated with the frequency
of airway CD8+CD161++TCRvα7.2+ T cells (Figure 5A). In
contrast, the frequency of airway CD8+CD161++TCRvα7.2+
T cells was not directly correlated with peripheral blood CD4
count (Figure 5B).
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FIGURE 4 | Depletion of airway CD103+CD8+CD161++TCRvα7.2+ T cells in untreated HIV-infected adults. BAL cells from HIV-uninfected and HIV-infected adults
were stained with fluorochrome-conjugated antibodies against surface markers of interest. (A) Flow cytometry dot plots showing depletion of
CD8+CD161++TCRvα7.2+ T cells. (B) Frequency of airway CD8+CD161++TCRvα7.2+ T cells in HIV-infected individuals compared to healthy controls (HIV−, n =
39; HIV+, n = 41). (C) Frequency of CD103+/− airway CD8+CD161++TCRvα7.2+ T cells in HIV-infected individuals compared to healthy controls (HIV−, n = 19;
HIV+, n = 21). (D) Frequency of total CD8+ T cells and CD4+ T cells in HIV-infected individuals compared to healthy controls (HIV−, n = 19; HIV+, n = 21). (E)
Distribution of CD103+/− airway CD161++TCRvα7.2+ T cells in HIV-infected individuals compared to healthy controls (HIV−, n = 19; HIV+, n = 21). (F) Association
between frequency of airway CD103+ CD8+CD161++TCRvα7.2+ T cells and proportion of airway CD4+ T cells (n = 40; HIV− n = 19, HIV+ n = 21). Data were
analyzed using Mann Whitney test and the horizontal bars represent median, and interquartile range (B,C,D). Data were analyzed using Fisher’s exact test (E). Data
was analyzed using Pearson correlation test (F). BAL, bronchoalveolar lavage.
To ascertain the impact of HIV viral burden on the depletion
of airway CD8+CD161++TCRvα7.2+ T cells, we investigated
whether suppressive antiretroviral therapy (ART) leads to
recovery of airway CD8+CD161++TCRvα7.2+ T cells. We
utilized 6 HIV-infected adults to which we had paired baseline
CD8+CD161++TCRvα+ T cell data before commencement
of ART and 1 year post ART initiation. All individuals had
undetectable HIV plasma viral load at 1 year post ART
initiation. Representative plots from anHIV-infected participant,
before and 1 year following ART initiation (Figure 5C).
Despite, having a small sample size, the frequency of airway
CD8+CD161++TCRvα7.2+ T cells increased 1 year following
initiation of ART (Figure 5D). Collectively, the findings show
that HIV could directly or indirectly drive depletion of airway
CD8+CD161++TCRvα7.2+ T cells and that ART leads to
reconstitution of these cells.
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FIGURE 5 | Depletion of airway CD8+CD161++TCRvα7.2+ T cells is inversely correlated with HIV plasma viral load. (A) Association between plasma viral load and
frequency of airway CD8+CD161++TCRvα7.2+ T cells. Plasma viral load was log transformed (n = 25). (B) Association between peripheral blood CD4 count and
frequency of airway CD8+CD161++TCRvα7.2+ T cells (n = 25). (C) Representative flow cytometry plots from an HIV-infected adult before and 1 year post ART
initiation. (D) Frequency of airway CD8+CD161++TCRvα7.2+ T cells in from HIV-uninfected adults (before and 1 year post ART initiation) compared to healthy
controls (HIV+ ART−/+, n = 6). Data was analyzed using Pearson correlation test (A,B). Data were analyzed using Wilcoxon matched-pairs signed rank test for
paired comparisons (D). ART, anti-retroviral therapy.
The Cytokine-Functional Profile of Airway
CD8+CD161++TCRvα7.2+ T Cells Is
Minimally Impacted by HIV Infection
Lastly, we investigated whether HIV infection alters cytokine
functional profile of airway CD8+CD161++TCRvα7.2+
T cells. Overall, the cytokine-producing functional
profile in airway CD8+CD161++TCRvα7.2+ T cells
was not different between untreated HIV-infected adults
compared to HIV-uninfected individuals, in both the
CD103+ and CD103− cells (Figures 6A,B). However,
frequency of CD103+IFN-γ+TNF+IL17A+-poly-functional
and CD103−IFN-γ−TNF+IL17A+-bi-functional airway
CD8+CD161++TCRvα7.2+ T cells was higher in HIV-
infected adults than HIV-uninfected controls (Figures 6A,B).
These results show that HIV infection, minimally but
differentially, impacts cytokine-functional profile of airway
CD8+CD161++TCRvα7.2+ T cell subsets.
DISCUSSION
CD8+CD161++TCRvα7.2+ T cells are part of the innate-
like T cell family with important functional relevance in
defense against a diverse repertoire of pathogens. There is
limited data on the phenotypic and functional characteristics
of human airway CD8+CD161++TCRvα7.2+ T cells and
how HIV impacts these cells in asymptomatic individuals
from high respiratory disease-burdened settings. This study
sheds new light on the functional capacity of human airway
CD8+CD161++TCRvα7.2+ T cells, their compartmentalized
nature, and demonstrates selective depletion of CD103
expressing airway CD8+CD161++TCRvα7.2+ T cells in
untreated HIV-infected African adults, and reconstitution of
airway CD8+CD161++TCRvα7.2+ T cells 1 year following
ART initiation.
Consistent with observations that CD8+CD161++
TCRvα7.2+ T cells possess different functional characteristics
related to their site of origin (12, 13, 39), we show
that airway CD8+CD161++TCRvα7.2+ T cells are
phenotypically and functionally different from those in
systemic circulation. Specifically, the majority of the
airway CD8+CD161++TCRvα7.2+ T cells express mucosal
retention receptor CD103, and are more poly-functional
than those from blood. Furthermore, CD103 expressing
CD8+CD161++TCRvα7.2+ T cells exhibited propensity for
IL-17A production. This is constituent with recent observations
Frontiers in Immunology | www.frontiersin.org 8 August 2019 | Volume 10 | Article 2003
Mvaya et al. Depletion of Airway CD103+CD8+CD161++TCRvα+ T Cells
FIGURE 6 | Function profile of CD8+CD161++TCRvα7.2+ T cells in healthy HIV-uninfected individuals compared to HIV-infected adults. BAL cells were stimulated
with PMA/Ionomycin for 6 h and responses were measured by intracellular cytokine staining for IL-17A, IFN-γ, and TNF. The phenotype of the responding cells was
obtained by gating on singlets, lymphocytes, viable (LIVE/ DEAD Aqua), CD3+ cells, CD8+ cells, IL-17A+, and then a combination of CD161 and CD103. (A)
CD103+ and (B) CD103−. Each pie chart (top) represents the mean distribution across subjects of mono-functional, bi-functional and poly-functional cytokine
producing cells (color coded as shown) within the total response in a particular CD8+CD161++TCRvα7.2+ T cell subset. Bar charts (bottom) represent the mean and
standard error of the mean (SEM) of the contribution of the indicated subset (x-axis) toward the total response against the indicated CD8+CD161++TCRvα7.2+ T cell
subsets (color coded as shown) (n = 11). Permutation test was performed among the pie charts and Wilcoxon test was done among the bar charts using SPICE
software (*p < 0.05). BAL, bronchoalveolar; IFN, interferon-gamma; TNF, tumor necrosis factor; IL17, interleukin-17A.
from the oral mucosa, showing MAIT cells that exhibit a
tissue-resident-activated profile biased toward IL-17 production
(44). IL-17 plays an important role in mucosal defense as it acts
as a bridge between innate and adaptive immunity (45–47) and
also induces production of antimicrobial peptides (48). Due to
the innate-like function of airway CD8+CD161++TCRvα7.2+
T cells, production of IL-17A and expression of CD103 likely
confers these cells readiness and immediate availability to
respond quickly to pathogens at a major portal of entry. This
is evidenced by observations in animal models that show poor
early control of respiratory infections in CD161++TCRvα7.2+ T
cell-deficient animals compared to wild type controls (32, 33).
Certainly, disruption of airway CD8+CD161++TCRvα7.2+
T cell homeostasis could contribute to increased susceptibility
to respiratory infections. Consistent with data from non-
human primates (49), we show a depletion in airway
CD8+CD161++TCRvα7.2+ T cells in untreated HIV-infected
adults. Specifically, we show that CD103 expressing airway
CD8+CD161++TCRvα7.2+ T cells are selectively depleted in
untreated HIV-infected adults. We also observed an inverse
correlation between HIV plasma viral load and frequency
of airway CD8+CD161++TCRvα7.2+ T cells, supporting
a direct or indirect role of HIV in depletion of these cells.
CD103 is required for retention of cells in tissues as it binds
to epithelial cell-expressed E-cadherin (41, 42). CD4+ T cells
are important for the formation of functional CD103+CD8+
T cells, and we have shown in this study that the frequency
of CD103 expressing airway CD8+CD161++TCRvα7.2+ T
cells was positively correlated with the frequency of airway
CD4+ T cells. It has been shown that absence of CD4+
T cells leads to reduced expression of CD103 on CD8+
T cells and subsequent mislocalization of these cells away
from airway epithelia (50). Downregulation of CD103 could
potentially result in egress of CD8+CD161++TCRvα7.2+ T
cells from the airway lumen. It is also plausible that HIV-
induced immune activation could lead activation-induced
cell death (AICD) (51), immune exhaustion (31) or to
upregulation of intergrins in the lung tissue, resulting in
impaired trafficking of CD8+ MAIT cells from the tissue into
the airway lumen. This could result in poor replenishment of
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CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells in
the airway lumen.
Consistent with a potential direct or indirect role of
HIV on alteration of airway CD8+CD161++TCRvα7.2+ T
cell homeostasis, suppressive ART was associated with a
reconstitution of airway CD8+CD161++TCRvα7.2+ T cells.
CD161++TCRvα7.2+ T cell reconstitution has also been
observed in colonic tissue fromHIV-infected individuals on ART
(52). In contrast to peripheral blood, where CD161++TCRvα+
T cell are not reconstituted by ART (36, 52), both colon
and respiratory mucosa have diverse microbiota rich with
potential CD161++TCRvα7.2+ T cell stimulating commensal
microbes (53). Microbial exposure shapes and maintains
the CD161++TCRvα7.2+ T cell repertoire (22). Germ-free
mice lack CD161++TCRvα7.2+ T cell, but acquire them
after reconstitution with commensal bacterial strains (20,
54). HIV infection disrupts the lung microbiota (55) and
this could compromise homeostatic maintenance of airway
CD161++TCRvα7.2+ T cells. ART-mediated suppression of
viremia could lead to changes in the respiratory microbiota that
favor recovery of CD161++TCRvα7.2+ T cell populations in the
mucosal compartments.
Interestingly, HIV was not associated with impairment
of cytokine-secreting functional potential in airway
CD8+CD161++TCRvα7.2+ T cells. This is consistent with
data showing retention of IFN-γ and TNF-producing function
in peripheral blood-derived CD161++TCRvα7.2+ T cells
stimulated with purified MR1 ligand in untreated HIV-
infected individuals (37). However, it is inconsistent with
results obtained following bacterial (E. coli) stimulation of
peripheral blood-derived CD161++TCRvα7.2+ T cells, which
showed lower levels of IFN-γ, TNF and IL-17 in untreated
HIV-infected individuals compared to healthy controls (38).
It is therefore, plausible, that the overpowering nature of
PMA/Ionomycin stimulation could mask the small differences
in function between airway CD8+CD161++TCRvα7.2+ T
cells from HIV-infected adults and HIV-uninfected controls.
On the other hand, PMA/Ionomycin stimulation brings out
the full cytokine-secreting functional potential of the airway
CD8+CD161++TCRvα7.2+ T cells and by-passes the need for
functional antigen-presentation, which could potentially skew
results in HIV-infected adults.
While our study provides useful insights into the phenotype
and function of airway CD8+CD161++TCRvα7.2+ T cells, we
acknowledge some limitations. First, we did not use MR1
tetramers or other surface markers (such as CD26) to identify
MAIT cells. However, we have used CD161 and TCRvα7.2,
classical MAIT cell markers used by most studies in literature,
as well as provided a representative flow cytometry plot showing
that over 70% of the CD8+CD161++TCRvα7.2+ T cells stain
positive forMR1-5-OP-RU Tetramer (Supplementary Figure 2).
Second, we were only able to perform serial bronchoscopy in
a subset of individuals due to challenges associated with serial
research bronchoscopy. However, the data from the small subset
of participants was consistent with the earlier observations that
showed an inverse correlation between HIV plasma viral load
and frequency of airway CD8+CD161++TCRvα7.2+ T cells.
Third, we were not able to further characterize the airway DN
CD161++TCRvα7.2+ T cells due to the limitation in event
numbers. However, in a subset, we were able to show that HIV
infection did not impact this airway DN CD161++TCRvα7.2+ T
cell population (Supplementary Figure 3).
In conclusion, we have shown that CD103 expressing airway
CD8+CD161++TCRvα7.2+ T cells are functionally distinct from
those in systemic circulation, and are preferentially depleted
during untreated asymptomatic HIV infection. Disruption of
airway CD8+CD161++TCRvα7.2+ T cell homeostasis likely
creates a conducive environment for susceptible respiratory
pathogens, and could partly contribute to the increased
propensity for LRTIs in HIV-infected adults.
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